Auditory Gain, Quality of Life, and Audiological Benefits in Bone-Anchored Hearing Device Users in Fundación Santafé De Bogotá, Colombia

HTML  XML Download Download as PDF (Size: 404KB)  PP. 44-53  
DOI: 10.4236/ijohns.2016.52008    3,119 Downloads   4,830 Views  Citations

ABSTRACT

The objective of this study is to determine the auditory gain, quality of life, audiological benefits, in bone-anchored hearing device users (BAHA). It is a retrospective and concurrent evaluation of thirty patients fitted unilaterally and seven fitted bilaterally for at least six months. Patients were assessed with audiometric testing and application of Glasgow Benefit Inventory (GBI) and Abbreviated Profile of Hearing Aid Benefit (APHAB). Regarding sound-field pure audiometry results, we found a statistically significant gain in all frequencies using the bone-anchored device. APHAB scores showed statistically significant subjective audiological gains in all subscales except for the aversiveness subscale. GBI mean scores for all items in both groups were all above 3, suggesting quality of life improvement in conductive and mixed hearing loss patients. BP100 users showed a greater clinical gain in the APHAB global score and subscales compared with Divino users. In conclusion the BAHA provides significant auditory gain, subjective audiological benefits and improves quality of life in all BAHA users. This study shows a significant clinical and statistical benefit of BAHA measured by audiometric testing and by the APHAB and GBI questionnaires.

Share and Cite:

Peñaranda, A. , Garcia, J. , Aparicio, M. , Montes, F. , Barón, C. , Jiménez, R. and Peñaranda, D. (2016) Auditory Gain, Quality of Life, and Audiological Benefits in Bone-Anchored Hearing Device Users in Fundación Santafé De Bogotá, Colombia. International Journal of Otolaryngology and Head & Neck Surgery, 5, 44-53. doi: 10.4236/ijohns.2016.52008.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.